HALO logo
halo search icon
NEU
Neuren Pharmaceuticals Limited

NEU · Neuren Pharmaceuticals Limited

16.50

AUD
-0.02 (-0.121%)
13/07/2026 04:10:12 PM
+1
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

AU$2.09B

PE

78.40

EV/EBITDA

97

DIV Yield

0%

Franking

0%

MQV Rating

1Very Strong

As at 13/07/2026 04:10:12 PM

Price Chart

Description

Neuren Pharmaceuticals Ltd. engages in the development of new therapies for neurodevelopmental disorders that emerge in early childhood. It operates through the Commercial Products, and Research and Development segments. The Commercial Products segment refers to the milestone and royalty revenue from license of intellectual property. The Research and Development segment focuses on the development of pharmaceutical products for the treatment of neurodevelopmental disorders. The company was founded on December 17, 2001 and is headquartered in Camberwell, Australia.

  • All-Companies
  • All-Consensus
  • Consensus Cheap
  • GROWTH AUS
  • HALO 200
  • HALO Balance Sheet
  • HALO Momentum
  • HALO MQV
  • HALO MQV SMALL
  • HALO Ords
  • HALO Price Momentum
  • HALO Small
  • Short Sold <-1 over the month

Key Fundamentals

EPS 3 yr Growth

15720.00%

EBITDA Margin

34.10%

Operating Cashflow

$125m

Free Cash Flow Return

35.70%

ROIC

8.70%

Interest Coverage

N/A

Quick Ratio

76.60

Performance

52 weeks range

Low 11 - 22.99

Trade Value (12mth)

AU$1,919,723.00

1 week

-1.31%

1 month

23.38%

YTD

-12.64%

1 year

13.23%

All time high

25.95

Additional Data

Shares Outstanding (Fully Diluted)

133m

HALO Sector

Healthcare

Next Company Report Date

24-Feb-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

AUD

Short Sell (% of issue)

4.90

Consensus

Lock Icon

Unlock full consensus

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Very Strong

Garp

Weak

Mqv Small

Very Strong

Momentum

Price

Very Strong

Earnings

Strong

Growth

Earnings

Neutral

Dividends

Very Weak

Quality

Capital Efficiency

Neutral

Balance Sheet

Very Strong

Valuation

Lock Icon

Unlock full dataset

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

DateEvent
29 June 26ASXD
18 June 26ASXD
01 June 26ASXD
01 June 26ASXD
27 May 26ASXD

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial
Want to learn more?Frequently asked questions.
1
What is the current share price of Neuren Pharmaceuticals Limited (NEU:ASX)?
Halo FAQ
The current share price of Neuren Pharmaceuticals Limited (NEU:ASX) is AUD$16.50.
2
What is the 52-week high share price for Neuren Pharmaceuticals Limited (NEU:ASX)?
Halo FAQ
The 52-week high share price for Neuren Pharmaceuticals Limited (NEU:ASX) is AUD$22.99.
3
What is the 52-week low share price for Neuren Pharmaceuticals Limited (NEU:ASX)?
Halo FAQ
The 52-week low share price for Neuren Pharmaceuticals Limited (NEU:ASX) is AUD$11.00.
4
What is the dividend yield for Neuren Pharmaceuticals Limited (NEU:ASX)?
Halo FAQ
Neuren Pharmaceuticals Limited (NEU:ASX) does not pay a dividend.
5
What was Neuren Pharmaceuticals Limited (NEU:ASX) last dividend payment?
Halo FAQ
Neuren Pharmaceuticals Limited (NEU:ASX) does not pay a dividend.
6
What is the franking level for Neuren Pharmaceuticals Limited (NEU:ASX)?
Halo FAQ
Neuren Pharmaceuticals Limited (NEU:ASX) has a franking level of 0.00%.
7
In which sector is Neuren Pharmaceuticals Limited (NEU:ASX) classified?
Halo FAQ
Neuren Pharmaceuticals Limited (NEU:ASX) is classified in the Healthcare.
8
What is the price-to-earnings (P/E) ratio for Neuren Pharmaceuticals Limited (NEU:ASX)?
Halo FAQ
The current P/E ratio for Neuren Pharmaceuticals Limited (NEU:ASX) is 78.40.